The veterinary vaccine market in the UK, excluding foot and mouth disease, reached an actual value of approximately 505 million USD in 2023. Forecasts indicate a gradual decline with values decreasing from 497.77 million USD in 2024 to 465.12 million USD by 2028. The year-on-year percentage change illustrates a consistent decrease, with each subsequent year's market size shrinking further. The compound annual growth rate (CAGR) over the five-year period highlights an average annual decline.

Future trends to watch for include:

The impact of technological advancements in vaccine development, potentially influencing market recovery.
Increasing demand for sustainable and organic livestock may drive innovation in vaccine formulations.
Policy changes, especially post-Brexit, could affect market dynamics and trade regulations.